Table 1.
Sample description
| Characteristics | Group | p-values +FoG vs−FoG | ||
|---|---|---|---|---|
| Control (Ct) | PD Non-Freezers (PD − FoG) | PD Freezers (PD + FoG) | ||
| Original sample (N = 111) | 40 | 42 | 29 | |
| Frame displacement th = 0.5 mm, all (N = 103) | 39 | 36 | 28 | |
| Age | 69.5 (7.71) | 69.2 (7.22) | 68.9 (7.39) | 0.89 |
| MDS-UPDRS III total | 36.5 (11.39) | 45.9 (14.89) | 0.01 | |
| Duration of disease (yr) | 5.9 (5.05) | 9.4 (6.58) | 0.02 | |
| MoCA | 26.9 (1.99) | 25.2 (3.48) | 25.1 (4.10) | 0.91 |
| LED medication | 683.9 (436.63) | 1404.6 (2189.11) | 0.07 | |
| Frame displacement th = 0.5 mm, matched (N = 81) | 27 | 27 | 27 | |
| Age | 69.4 (6.35) | 69.6 (7.87) | 68.6 (7.50) | 0.63 |
| MDS-UPDRS III total | 39.6 (12.97) | 47.0 (15.77) | 0.07 | |
| Duration of disease (yr) | 6.8 (4.55) | 9.8 (6.81) | 0.06 | |
| MoCA | 26.8 (2.28) | 24.7 (4.11) | 25.7 (4.02) | 0.34 |
| LED medication | 735.1 (452.43) | 1374.6 (2106.00) | 0.13 | |
| Frame displacement th = 0.3 mm, all (N = 75) | 27 | 27 | 21 | |
| Age | 68.6 (8.15) | 69.0 (7.42) | 69.3 (6.17) | 0.90 |
| MDS-UPDRS III total | 35.0 (11.28) | 43.9 (13.42) | 0.02 | |
| Duration of disease (yr) | 5.6 (4.44) | 7.8 (5.55) | 0.13 | |
| MoCA | 27.0 (1.77) | 24.8 (3.64) | 25.5 (4.18) | 0.53 |
| LED medication | 667.9 (481.05) | 1525.3 (2437.50) | 0.08 | |
| Frame displacement th = 0.3 mm, matched (N = 43) | 16 (4/12) | 14 (4/10) | 13 (4/9) | |
| Age (years) | 70.3 (7.3) | 68.0 (7.8) | 67.5 (6.0) | 0.86 |
| MDS-UPDRS III total | NA | 37.6 (9.0) | 40.4 (13.0) | 0.53 |
| Duration of disease (yr) | NA | 4.49 (4.8) | 8.88 (4.8) | 0.03 |
| MoCA | 27.1 (1.9) | 24.0 (3.4) | 25.9 (3.4) | 0.16 |
| LED medication | 573 (357.1) | 594 (364.7) | 0.12 | |
Sample size reported in “count”. Number in parenthesis indicates male/female count. Mean (standard deviation) reported for the other variables. MDS-UPDRS: Movement Disorders Society Unified Parkinson’s Disease Rating Scale. MoCA: Montreal Cognitive Assessment. LEDD: Levodopa equivalent daily dosage. yr: years.